Kara Lassen
Directeur/Membre du Conseil chez MOONLAKE IMMUNOTHERAPEUTICS
Postes actifs de Kara Lassen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Directeur/Membre du Conseil | 05/04/2022 | - |
| Independent Dir/Board Member | 05/04/2022 | - | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/04/2019 | - |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Kara Lassen
Formation de Kara Lassen
| Wake Forest University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistiques
Internationale
| Suisse | 4 |
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Entreprise privées | 2 |
|---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
- Bourse
- Insiders
- Kara Lassen
- Expérience
